SCHEMBL6606928

SCHEMBL6606928

CCCN(CCC)c1cc(C(=O)NCC(O)CC(Cc2cc(F)cc(F)c2)c2ccn[nH]2)cc(-c2ncco2)n1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 9/20 0.36
BACE2 Q9Y5Z0 5/20 0.32
CTSD P07339 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6043722 0.79 BACE1 (0.43) BACE1BACE2CTSD
SCHEMBL6043432 0.78 BACE1 (0.54) BACE1BACE2CTSD
SCHEMBL6044654 0.77 BACE1 (0.39) BACE1
SCHEMBL6043902 0.74 BACE1 (0.43) BACE1BACE2CTSD
SCHEMBL6044292 0.73 BACE1 (0.45) BACE1BACE2CTSD
SCHEMBL6044082 0.73 BACE1 (0.43) BACE1BACE2CTSD
SCHEMBL3352804 0.72 BACE1 (0.61) BACE1BACE2CTSD
SCHEMBL3352797 0.72 BACE1 (0.61) BACE1BACE2CTSD
SCHEMBL6044454 0.71 BACE1 (0.42) BACE1BACE2CTSD
SCHEMBL6043285 0.71 BACE1 (0.41) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430032-A2 SUBSTITUTED AMIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Elan Pharmaceuticals, Inc. (US) 2004-06-23 EP claimed
WO-2003027068-A2 SUBSTITUTED AMINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS ELAN PHARMACEUTICALS, INC. (US) 2003-04-03 WO claimed